# Claritev Corp: Form 10-Q for the period ended Sep 30, 2021

- Company: [Claritev Corp](/companies/ctev.md) (CIK 1793229)
- Form: 10-Q
- Filed: 2021-11-04
- Accepted by EDGAR: Nov 4, 2021, 08:00 ET
- Period: 2021-09-30
- Accession: 0001793229-21-000106
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1793229/000179322921000106/mpln-20210930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1793229/000179322921000106/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-07-01 to 2021-09-30 | $288.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2021-01-01 to 2021-09-30 | $819.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating income | 3 months, 2021-07-01 to 2021-09-30 | $104.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2021-01-01 to 2021-09-30 | $276.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-07-01 to 2021-09-30 | $67.5m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2021-01-01 to 2021-09-30 | $195.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-07-01 to 2021-09-30 | $19.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2021-01-01 to 2021-09-30 | $23.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-07-01 to 2021-09-30 | $78.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2021-01-01 to 2021-09-30 | $77.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-07-01 to 2021-09-30 | $0.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2021-01-01 to 2021-09-30 | $0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-07-01 to 2021-09-30 | $0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2021-01-01 to 2021-09-30 | $0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-07-01 to 2021-09-30 | 652,882,405 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2021-01-01 to 2021-09-30 | 654,816,495 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2021-01-01 to 2021-09-30 | $371.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2021-01-01 to 2021-09-30 | $57.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2021-01-01 to 2021-09-30 | $61.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-09-30 | $225.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-09-30 | $306.2m | us-gaap:AssetsCurrent |
| Total assets | at 2021-09-30 | $8.28bn | us-gaap:Assets |
| Current liabilities | at 2021-09-30 | $167.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-09-30 | $5.92bn | us-gaap:Liabilities |
| Shareholders' equity | at 2021-09-30 | $2.36bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 69,969 characters.

*The following discussion and analysis of the Company’s financial condition and results should be read in conjunction with the unaudited condensed consolidated financial statements and accompanying notes thereto contained elsewhere in this Quarterly Report and together with the information included in the Company’s 2020 Annual Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties; the results described below are not necessarily indicative of the results to be expected in any future periods.*

### Cautionary Note Regarding Forward-looking Statements

All statements other than statements of historical fact included in this Quarterly Report including, without limitation, statements under this “*Management’s Discussion and Analysis of Financial Condition and Results of Operations”* regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 or Section 21E of the Securities Exchange Act of 1934, each as amended, including, in particular, statements about our plans, strategies and prospects as well as estimates of industry growth for the next quarter and beyond. When used in this Quarterly Report, words such as “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may,” “will” or “should” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They may appear in a number of places throughout this Quarterly Report and these forward-looking statements reflect management’s expectations regarding our future growth, results of operations, operational and financial performance and business prospects and opportunities. Such forward-looking statements are based on available current market material and management’s expectations, beliefs and forecasts concerning future events impacting our business. Factors that may impact such forward-looking statements include:

- the impact of COVID-19 and its related effects on our projected results of operations, financial performance or other financial metrics;
- loss of our customers, particularly our largest customers;
- decreases in our existing market share or the size of our Preferred Provider Organization (“PPO”) networks;
- effects of competition;
- effects of pricing pressure;
- the inability of our customers to pay for our services;
- decreases in discounts from providers;
- the loss of our existing relationships with providers;
- the loss of key members of our management team;
- pressure to limit access to preferred provider networks;
- the ability to achieve the goals of our strategic plans and recognize the anticipated strategic, operational, growth and efficiency benefits when expected;
- our ability to identify, complete and successfully integrate acquisitions;
- changes in our industry;
- interruptions or security breaches of our information technology systems and other cyber security attacks;
- our ability to protect proprietary applications;
- our inability to expand our network infrastructure;
- our ability to remediate any material weaknesses or maintain effective internal controls over financial reporting;
- changes in our regulatory environment, including healthcare law and regulations;
- the expansion of privacy and security laws;
- heightened enforcement and investigations activity by government agencies;
- our ability to pay interest and principal on our notes and other indebtedness;
- the possibility that we may be adversely affected by other political, economic, business, and/or competitive factors;
- other factors disclosed in this Quarterly Report; and
- other factors beyond our control.

The forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effects on our business. There can be no assurance that future developments affecting our business will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors referred to under the heading “*Risk Factors”* in Part II, Item 1A of this Quarterly Report or as described in our 2020 Annual Report. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

### Company Overview

MultiPlan is a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry. We are also one of the largest independent PPOs in the U.S., with contracted providers in all 50 states and the District of Columbia. We are committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics and a team-rich industry experience, MultiPlan interprets clients' needs and customizes innovative solutions through the following offerings:

- Analytics-Based Services: data-driven algorithms which detect claims over-charges and recommend or negotiate fair reimbursement;
- Network-Based Services: contracted discounts with healthcare providers, including one of the largest independent preferred provider organizations in the United States, and outsourced network development and/or management services; and
- Payment and Revenue Integrity Services: data, technology, and clinical expertise deployed to identify and remove improper and unnecessary charges before or after claims are paid, or to identify and help restore and preserve underpaid premium dollars.

Our customers almost entirely are payors. We offer these payors a single electronic gateway to a comprehensive set of services in each of the three categories (Analytics-Based Services, Network-Based Services, and Payment and Revenue Integrity Services), which are used in combination or individually to reduce the medical cost burden on healthcare payors and patients while fostering efficient payments to the providers. These offerings have enabled us to maintain long-term relationships with a number of our customers, including relationships of over 25 years with some of the nation’s largest commercial payors. For the nine months ended September 30, 2021 and year ended December 31, 2020 our expansive network included access to over 1.2 million healthcare providers. Our comprehensive services identified approximately $16.0 billion and $18.8 billion in potential medical cost savings in the nine months ended September 30, 2021 and year ended December 31, 2020, respectively.

### Uncertainty Relating to the COVID-19 Pandemic

As discussed above in Note 1 General Information and Basis of Accounting of the notes to the unaudited condensed consolidated financial statements included in this Quarterly Report, COVID-19 has negatively impacted our business, results of operations and financial condition during 2020 and the nine months ended September 30, 2021.

We temporarily closed all of our offices and restricted travel due to concern for our employees' health and safety and also in compliance with state orders. Most of our approximately 2,400 employees continue to work remotely. Other than these modifications, we have not experienced any material changes to our operations including receiving and processing transactions with our customers as a result of COVID-19.

Effects from COVID-19 began to impact our business in first quarter 2020 with various federal, state, and local governments and private entities mandating restrictions on travel, restrictions on public gatherings, closure of non-essential commerce, and shelter in place orders. The Company experienced an approximately 4.6% decline in revenues for the year ended December 31, 2020 as compared to 2019 primarily due to reduced volume from customers as a result of restrictions on elective medical procedures and non-essential medical services. For the three and nine months ended September 30, 2021, the Company's revenues continue to be negatively impacted, but to a lesser extent compared to 2020 as vaccination rates have increased and restrictions on medical services have been lifted. The extent of the ultimate impact of COVID-19 will depend on the severity and duration of the pandemic. Future developments remain uncertain, including the number of confirmed cases, the emergence of highly contagious variants, and any actions taken by federal, state and local governments such as economic relief efforts, as well as U.S. and global economies, consumer behavior and healthcare utilization patterns.

In connection with the COVID-19 pandemic, the CARES Act was enacted on March 27, 2020 and included certain changes to corporate income taxes. Specifically, the CARES Act provided numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement property, and the creation of certain payroll tax credits associated with the retention of employees. We assessed these impacts and noted the largest impact is due to the tax law change related to the interest disallowance rules retroactive to 2019. The other aspects of the CARES Act did not have a material effect on us.

### Factors Affecting Our Results of Operations

### Medical Cost Savings

Our business and revenues are driven by the ability to lower medical costs through claims savings for our customers. The medical charges of those claims can influence our ability to generate claim savings.

The following table presents the medical charges processed and the potential savings identified for the periods presented:

*(in billions)*

|  | Nine Months Ended September 30, 2021 | 2020 |
| --- | ---: | ---: |
| Medical charges processed(1)(3) | $88.7 | $75.0 |
| Potential medical cost savings(2)(3) | $16.0 | $13.7 |

(1) Medical charges processed represent the aggregate dollar amount of claims processed by our cost management solutions in the period presented. The dollar amount of the claim for purposes of this calculation is the dollar amount of the claim prior to any reductions that may be made as a result of the claim being processed by our cost management solutions. Medical charges processed includes medical charges processed on HST acquired claims of $1.4 billion for the nine months ended September 30, 2021 and no medical charges processed by HST were included for 2020. Medical charges processed exclude medical charges processed by DHP in both time periods.

(2) Potential medical cost savings represent the aggregate amount of potential savings in dollars identified by our cost management solutions in the period presented. Since certain of our fees are based on the amount of savings achieved by our customers and our customers are the final adjudicator of the claims and may choose not to reduce claims or reduce claims by only a portion of the potential savings identified, potential medical cost savings may not directly correlate with the amount of fees earned in connection with the processing of such claims. Potential medical cost savings includes potential medical cost savings identified on HST acquired claims of $1.0 billion for the nine months ended September 30, 2021 and no potential medical cost savings for HST were included for 2020. Potential medical cost savings exclude potential medical cost savings identified by DHP in both time periods.

(3) Changes to previously reported medical charges processed and potential medical cost savings are due to client claim resubmissions or cancellation of claims. Examples of these changes include, but are not limited to, adjudication changes, billing changes, and elimination of claims that were later determined to be invalid. In second quarter 2021, we introduced a change in methodology to exclude from the current and prior periods certain claims, the inclusion of which distorts the underlying trends in our core claim processing activities. We believe this change in methodology improves the comparability of current and prior periods.

Our medical charges processed and potential medical cost savings figures may not be directly comparable from period to period due to the completion and integration of acquisitions made in a particular period.

### Components of Results of Operations

### Revenues

We generate revenues from several sources including: (i) Analytics-Based Services that use our leading and proprietary information technology platform to offer customers solutions to reduce medical costs, (ii) Network-Based Services that process claims at a discount compared to billed fee-for-service rates and by using an extensive network and (iii) Payment and Revenue Integrity Services that use data, technology, and clinical expertise to identify improper, unnecessary and excessive charges. Payors typically compensate us through either a PSAV achieved or a PEPM rate.

### Costs of Services (exclusive of depreciation and amortization of intangible assets)

Costs of services (exclusive of depreciation and amortization of intangible assets) consist of all costs specifically associated with claims processing activities for customers, sales and marketing, and the development and maintenance of our networks, analytics-based services, and payment and revenue integrity services. Two of the largest components in costs of services are personnel expenses and access and bill review fees. Access and bill review fees include fees for accessing non-owned third-party provider networks, expenses associated with vendor fees for database access and systems technology used to reprice claims, and outsourced services. Third-party network expenses are fees paid to non-owned provider networks used to supplement our owned network assets to provide more network claim savings to our customers.

### General and Administrative Expenses

General and administrative expenses include corporate management and governance functions composed of general management, legal, treasury, tax, real estate, financial reporting, auditing, benefits and human resource administration, communications, public relations, billing and information management. In addition, general and administrative expenses include taxes, insurance, advertising, transaction costs, and other general expenses.

### Depreciation Expense

Depreciation expense consists of depreciation and amortization of property and equipment related to our investments in leasehold improvements, furniture and equipment, computer hardware and software, and internally generated capitalized software development costs. We provide for depreciation and amortization on property and equipment using the straight-line method to allocate the cost of depreciable assets over their estimated useful lives.

### Amortization of intangible assets

Amortization of intangible assets includes amortization of the value of our customer relationships, provider network, technology, and trademarks which were identified in valuing the intangible assets in connection with the June 6, 2016 acquisition by H&F, as well as recent acquisitions of HST and DHP by the Company.

### Interest expense

Interest expense consists of accrued interest and related interest payments on our outstanding long-term debt and amortization of debt issuance costs, discounts and premiums.

### Interest income

Interest income consists primarily of bank interest.

### Loss on extinguishment of debt

The Company recognizes a loss on extinguishment of debt for the difference between the net carrying amount of the extinguished debt immediately before the refinancing and the fair value of the new debt instruments, and fees associated with the issuance of the new debt under the refinancing.

### Change in fair value of Private Placement Warrants and unvested founder shares

The Company remeasures at each reporting period the fair value of the Private Placement Warrants and unvested founder shares. The changes for the three and nine months ended September 30, 2021 were primarily due to the change in the stock price of the Company's Class A common stock over the reporting period.

### Income tax expense (benefit)

Income tax expense (benefit) consists of federal, state, and local income taxes.

### Non-GAAP Financial Measures

We use EBITDA, Adjusted EBITDA and Adjusted EPS to evaluate our financial performance. EBITDA, Adjusted EBITDA and adjusted EPS are financial measures that are not presented in accordance with GAAP. We believe the presentation of these non-GAAP financial measures provides useful information to investors in assessing our financial condition and results of operations across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our financial operating results of our core business.

These measurements of financial performance have important limitations as analytical tools and should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. Additionally, they may not be comparable to other similarly titled measures of other companies. Some of these limitations are:

- such measures do not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments;
- such measures do not reflect changes in, or cash requirements for, our working capital needs;
- such measures do not reflect the significant interest expense, or cash requirements necessary to service interest or principal payments on our debt;
- such measures do not reflect any cash requirements for any future replacement of depreciated assets;
- such measures do not reflect the impact of stock-based compensation upon our results of operations;
- such measures do not reflect our income tax (benefit) expense or the cash requirements to pay our income taxes;
- such measures do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations; and
- other companies in our industry may calculate these measures differently from how we do, limiting their usefulness as a comparative measure.

In evaluating EBITDA, Adjusted EBITDA and Adjusted EPS, you should be aware that in the future we may incur expenses similar to those eliminated in the presentation.

EBITDA, Adjusted EBITDA, and Adjusted EPS are widely used measures of corporate profitability eliminating the effects of financing and capital expenditures from the operating results. We define EBITDA as net income (loss) adjusted for interest expense, interest income, income tax (benefit) expense, depreciation, amortization of intangible assets, and non-income taxes. We define Adjusted EBITDA as EBITDA further adjusted to eliminate the impact of certain items that we do not consider to be indicative of our core business, including other expenses, change in fair value of Private Placement Warrants and unvested founder shares, transaction related expenses, loss (gain) on the debt extinguishment, loss (gain) on investments and stock-based compensation. See our unaudited condensed consolidated financial statements included in this Quarterly Report for more information regarding these adjustments. Adjusted EBITDA is used in our agreements governing our outstanding indebtedness for debt covenant compliance purposes. Our Adjusted EBITDA calculation is consistent with the definition of Adjusted EBITDA used in our debt instruments.

Adjusted EPS is used in reporting to our Board and executive management and as a component of the measurement of our performance. We believe that this measure provides useful information to investors because it is the profitability measure we use to evaluate earnings performance on a comparable year-to-year basis. Adjusted EPS is defined as net income (loss) adjusted for amortization of intangible assets, stock-based compensation, transaction related expenses, loss (gain) on investments, loss (gain) on debt extinguishment, other expense, change in fair value of Private Placement Warrants and unvested founder shares and tax effect of adjustments to arrive at Adjusted net income divided by our basic weighted average number of shares outstanding.

The following table presents a reconciliation of net loss to EBITDA and Adjusted EBITDA for the periods presented:

*(in thousands)*

|  | Three Months Ended September 30, 2021 | 2020 | Nine Months Ended September 30, 2021 | 2020 |
| --- | ---: | ---: | ---: | ---: |
| Net income (loss) | $78,197 | $(288,402) | $77,142 | $(347,242) |
| Adjustments: |  |  |  |  |
| Interest expense | 67,512 | 82,275 | 195,233 | 259,290 |
| Interest income | (8) | (81) | (19) | (229) |
| Income tax provision (benefit) | 19,565 | (1,080) | 23,817 | (11,219) |
| Depreciation | 15,783 | 15,262 | 48,956 | 44,903 |
| Amortization of intangible assets | 85,167 | 83,513 | 255,042 | 250,540 |
| Non-income taxes | 105 | 415 | 1,107 | 1,335 |
| EBITDA | $266,321 | $(108,098) | $601,278 | $197,378 |
| Adjustments: |  |  |  |  |
| Other expenses | 1,685 | 297 | 2,396 | 566 |
| Integration expenses | 4,875 | 715 | 9,563 | 743 |
| Change in fair value of Private Placement Warrants and unvested founder shares | (76,636) | — | (35,451) | — |
| Transaction-related expenses | 1,541 | 2,464 | 7,972 | 5,162 |
| Loss (gain) on investments | — | 7,784 | (25) | 7,784 |
| Loss on extinguishment of debt | 15,823 | — | 15,823 | — |
| Stock-based compensation | 4,752 | 262,356 | 13,194 | 299,628 |
| Adjusted EBITDA | $218,361 | $165,518 | $614,750 | $511,261 |

Material differences between MultiPlan Corporation and MPH for the three and nine months ended September 30, 2021 include differences in interest expense, change in fair value of Private Placement Warrants and unvested founder shares, and stock-based compensation. For the three and nine months ended September 30, 2021, interest expense for MultiPlan Corporation is $20.5 million and $61.4 million higher than interest expense, respectively, for MPH due to interest expense incurred by MultiPlan Corporation on the Senior Convertible PIK Notes (issued on October 8, 2020). For the three and nine months ended September 30, 2021, the change in fair value of Private Placement Warrants and unvested founder shares, and stock-based compensation are recorded in the parent company MultiPlan Corporation and not in the MPH operating company and therefore represent differences between MultiPlan Corporation and MPH.

The following table presents a reconciliation of net loss to Adjusted EPS for the periods presented:

*($ in thousands, except share and per share amounts)*

| 2021 | Three Months Ended September 30, 2020 | 2021 | Nine Months Ended September 30, 2020 |  |
| --- | ---: | ---: | ---: | ---: |
| Net income (loss) | $78,197 | $(288,402) | $77,142 | $(347,242) |
| Adjustments: |  |  |  |  |
| Amortization of intangible assets | 85,167 | 83,513 | 255,042 | 250,540 |
| Stock-based compensation | 4,752 | 262,356 | 13,194 | 299,628 |
| Transaction-related expenses | 1,541 | 2,464 | 7,972 | 5,162 |
| Loss (gain) on investments | — | 7,784 | (25) | 7,784 |
| Loss on extinguishment of debt | 15,823 | — | 15,823 | — |
| Other expenses | 1,685 | 297 | 2,396 | 566 |
| Integration expenses | 4,875 | 715 | 9,563 | 743 |
| Change in fair value of Private Placement Warrants and unvested founder shares | (76,636) | — | (35,451) | — |
| Estimated tax effect of adjustments | (26,564) | (20,877) | (73,764) | (61,679) |
| Adjusted net income | $88,840 | $47,850 | $271,892 | $155,502 |
| Weighted average shares outstanding – Basic | 652,520,691 | 415,700,000 | 654,414,644 | 415,700,000 |
| Net loss per share – basic | $0.12 | $(0.69) | $0.12 | $(0.84) |
| Adjusted EPS | $0.14 | $0.12 | $0.42 | $0.37 |

### Factors Affecting the Comparability of our Results of Operations

As a result of a number of factors, our historical results of operations may not be comparable to our results of operations in future periods and may not be directly comparable from period to period. Set forth below is a brief discussion of the key factors impacting the comparability of our results of operations.

### The Transactions

On July 12, 2020, Churchill entered into the Merger Agreement by and among First Merger Sub, Second Merger Sub, Holdings, and MultiPlan Parent. On October 8, 2020, the Merger Agreement was consummated and the Transactions were completed.

The Transactions were accounted for as a reverse recapitalization, with no goodwill or other intangible assets recorded, in accordance with GAAP. Under this method of accounting, Churchill was treated as the "acquired" company for financial reporting purposes with MultiPlan Parent determined to be the accounting acquiror. This determination was primarily based on the existing MultiPlan Parent stockholders being the majority stockholders and holding majority voting power in the combined company, MultiPlan Parent's senior management comprising the majority of senior management of the combined company, and the ongoing operations of MultiPlan Parent comprising the ongoing operations of the combined company. Accordingly, for accounting purposes, the Transactions were treated as the equivalent of MultiPlan Parent issuing shares for the net assets of Churchill, accompanied by a recapitalization. The net assets of Churchill were recognized at fair value (which were consistent with carrying value), with no goodwill or other intangible assets recorded. See Note 1 General Information and Basis of Accounting of the notes to the unaudited condensed consolidated financial statements included in this Quarterly Report for further information on the Transactions.

As a consequence of the Transactions, we became the successor to a SEC-registered and NYSE-listed company.

### HST Acquisition

On November 9, 2020, the Company acquired HST, a healthcare technology company that enables value-driven health benefit plan designs featuring reference-based pricing and tools to engage health plan members and providers in making the best use of available benefits both before and after care delivery. The Company acquired 100 percent of the voting equity interests of HST.

The results of operations and financial condition of HST have been included in the Company's consolidated results from the date of acquisition. Through September 30, 2021, HST's impact on revenues and net earnings was not material.

### DHP Acquisition

On February 26, 2021, the Company completed the acquisition of DHP, an analytics and technology company offering healthcare payment and revenue integrity services. The Company acquired 100 percent of the voting equity interest of DHP. The acquisition strengthens MultiPlan's service offering in the payment integrity market with new and complementary services to help its payor customers manage the overall cost of care and improve their competitiveness. It also adds revenue integrity services for plans that receive premiums from the Centers for Medicare and Medicaid Services.

The results of operations and financial condition of DHP have been included in the Company's consolidated results from the date of acquisition. Through September 30, 2021, DHP's impact on revenues and net earnings was not material. In connection with the DHP acquisition, the Company incurred transaction-related expenses of $0.6 million for the year ended December 31, 2020 and $0.1 million and $4.7 million for the three and nine months ended September 30, 2021, respectively. The transaction-related expenses have been expensed as incurred and are included in general and administrative expenses in the accompanying unaudited condensed consolidated statements of income (loss) and comprehensive income (loss).

### Debt Refinancings, Repayments and Repricing

On October 8, 2020, the Company issued $1,300.0 million in aggregate principal amount of the Senior Convertible PIK Notes. The Senior Convertible PIK Notes were issued with a 2.5% discount and a maturity date of October 15, 2027. The Senior Convertible PIK Notes will accrue interest at a rate per annum equal to six percent (6.00%) with respect to Cash Interest and seven percent (7.00%) with respect to PIK Interest. The Company must elect prior to the third business day prior to any interest payment date to pay Cash Interest or PIK Interest for such interest period; provided that prior to any such election, the Company is deemed to have selected Cash Interest.

On October 8, 2020, we redeemed the Senior PIK Notes in full at a redemption price of 102.000% of the principal amount plus accrued and unpaid interest for a total redemption price of $1,237.6 million.

On October 29, 2020, MPH issued $1,300.0 million in aggregate principal amount of its 5.750% Notes and redeemed the 7.125% Notes in full at a redemption price of 103.563% of the principal amount plus accrued and unpaid interest for a total redemption price of $1,661.3 million. The Company also entered into an amendment to increase the commitments under its senior secured revolving credit facility from $100.0 million to $450.0 million.

On October 29, 2020, we made a principal prepayment of the Term Loan G in the amount of $369.0 million. This prepayment reduces interest expense for Term Loan G for this and future time periods.

On August 24, 2021, MPH issued new senior secured credit facilities comprised of $1,325.0 million of Term Loan B and $450.0 million of a Revolver B, and $1,050.0 million in aggregate principal amount of 5.50% Senior Secured Notes. MPH used the net proceeds from Term Loan B, issued with a discount of 1.00%, and the 5.50% Senior Secured Notes to repay all of the outstanding balance of its Term Loan G for a total redemption price of $2,354.6 million, and pay fees and expenses in connection therewith.

Interest on Term Loan B and Revolver B is calculated, at MPH’s option, as (a) LIBOR (or, with respect to Term Loan B only, 0.50%, if higher), plus the applicable margin, or (b) the highest rate of (1) the prime rate, (2) the federal funds effective rate, plus 0.50%, (3) the LIBOR for an interest period of one month, plus 1.00% and (4) 0.50% for Term Loan B and 1.00% for Revolver B, in each case, plus an applicable margin of 4.25% for Term Loan B and between 3.50% and 4.00% for Revolver B, depending on MPH’s first lien debt to consolidated EBITDA ratio. The interest rate in effect for Term Loan B was 4.75% as of September 30, 2021 and the interest rate in effect for Term Loan G was 3.75% as of September 30, 2020.

The Company is obligated to pay a commitment fee on the average daily unused amount of Revolver B. The annual commitment fee can range from an annual rate of 0.25% to 0.50% based on the Company's first lien debt to consolidated EBITDA ratio, as defined in the agreement.

The interest rate on the 5.50% Senior Secured Notes is fixed at 5.50%, and is payable semi-annually on March 1 and September 1 of each year.

In connection with the issuance of our debt instruments, the Company incurred specific expenses related to raising the debt, including commissions, fees and expenses of investment bankers and underwriters, registration and listing fees, accounting and legal fees pertaining to the financing and other external, incremental expenses paid to advisors that were directly attributable to realizing the proceeds of the debt issues. These costs were capitalized and are being amortized over the term of the related debt using the effective interest method. The amortization of the debt issuance costs, premiums and discounts are included in interest expense in the accompanying unaudited condensed consolidated statements of income (loss) and comprehensive income (loss).

In connection with the August 24, 2021 refinancing, the Company wrote off $2.7 million of the term loan discount and $6.4 million of debt issuance costs, and incurred an expense of $6.7 million for lender and third party fees. These amounts are included in Loss on extinguishment of debt in the accompanying consolidated statements of (loss) income and comprehensive (loss) income.

In the years ended December 31, 2019, 2018, and 2017, we did not recognize expense for the portions of debt issuance costs related to the amounts of the principal loan prepayments of Term Loan G made in each year, which resulted in an understatement of long-term debt of $2.3 million as of December 31, 2019. We corrected this error as an out-of-period adjustment resulting in an overstatement of interest expense of $2.3 million in the nine months ended September 30, 2020.

### Stock-Based Compensation

Prior to the consummation of the Transactions, we were a wholly owned subsidiary of Holdings and our stock-based compensation was granted to employees in the form of Units via a Class B Unit Award Agreement. The fair value of the Units was remeasured at each reporting period. The consummation of the Transactions constituted a definitive Liquidity Event under the agreements governing the Unit awards and as a result the incentive plan was liquidated. For the three and nine months ended September 30, 2020, the Company recorded stock-based compensation expense under the Class B Unit Award Agreement of $262.4 million and $299.6 million, respectively, in the accompanying unaudited condensed consolidated statements of income (loss) and comprehensive income (loss).

Since the consummation of the Transactions, the Company has operated under the 2020 Omnibus Incentive Plan effective October 8, 2020. To date, awards granted under the 2020 Omnibus Incentive Plan have been in the form of Employee RS, Employee RSUs, Fixed Value RSUs, Employee NQSOs and Director RSUs. Stock-based compensation is measured at the grant date based on the fair value of the award.

During the nine months ended September 30, 2021, the Company has granted 2.5 million Employee NQSOs, 2.9 million Employee RSUs, 0.1 million Employee RS, 0.3 million Fixed Value RSUs and 0.1 million Director RSUs under the 2020 Omnibus Incentive Plan. For the three and nine months ended September 30, 2021, the Company recorded stock-based compensation expense under the 2020 Omnibus Incentive Plan of $4.8 million and $13.2 million, respectively, in the accompanying unaudited condensed consolidated statements of income (loss) and comprehensive income (loss).

### Results of Operations for the Three and Nine Months Ended September 30, 2021 and 2020

The following table provides the results of operations for the periods indicated:

*($ in thousands)*

| Revenues | Three Months Ended September 30, 2021 | 2020 | Change $% |  | Nine Months Ended September 30, 2021 | 2020 | Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Network-Based Services | $66,966 | $65,323 | $1,643 | 2.5% | $208,404 | $200,448 | $7,956 | 4.0% |
| Analytics-Based Services | 185,812 | 133,119 | 52,693 | 39.6% | 513,765 | 407,216 | 106,549 | 26.2% |
| Payment and Revenue Integrity Services | 35,434 | 25,075 | 10,359 | 41.3% | 97,179 | 74,755 | 22,424 | 30.0% |
| **Total Revenues** | $288,212 | $223,517 | $64,695 | 28.9% | $819,348 | $682,419 | $136,929 | 20.1% |
| **Costs of services (exclusive of depreciation and amortization of intangible assets shown below)** |  |  |  |  |  |  |  |  |
| Personnel expenses excluding stock-based compensation | 38,463 | 31,961 | 6,502 | 20.3% | 108,660 | 95,745 | 12,915 | 13.5% |
| Stock-based compensation | 1,719 | 108,777 | (107,058) | (98.4)% | 2,171 | 126,723 | (124,552) | (98.3)% |
| Personnel expenses including stock-based compensation | 40,182 | 140,738 | (100,556) | (71.4)% | 110,831 | 222,468 | (111,637) | (50.2)% |
| Access and bill review fees | 2,810 | 3,583 | (773) | (21.6)% | 9,746 | 10,889 | (1,143) | (10.5)% |
| Other cost of services expenses | 1,596 | 3,545 | (1,949) | (55.0)% | 8,109 | 11,088 | (2,979) | (26.9)% |
| **Total costs of services (exclusive of depreciation and amortization of intangible assets shown below)** | 44,588 | 147,866 | (103,278) | (69.8)% | 128,686 | 244,445 | (115,759) | (47.4)% |
| General and administrative expenses excluding stock-based compensation and transaction-related expenses | 33,647 | 20,337 | 13,310 | 65.4% | 91,149 | 56,080 | 35,069 | 62.5% |
| Stock-based compensation | 3,033 | 153,579 | (150,546) | (98.0)% | 11,023 | 172,905 | (161,882) | (93.6)% |
| Transaction-related expenses | 1,541 | 2,464 | (923) | (37.5)% | 7,972 | 5,162 | 2,810 | 54.4% |
| **Total general and administrative expenses** | 38,221 | 176,380 | (138,159) | (78.3)% | 110,144 | 234,147 | (124,003) | (53.0)% |
| Depreciation expense | 15,783 | 15,262 | 521 | 3.4% | 48,956 | 44,903 | 4,053 | 9.0% |
| Amortization of intangible assets | 85,167 | 83,513 | 1,654 | 2.0% | 255,042 | 250,540 | 4,502 | 1.8% |
| **Operating income (loss)** | 104,453 | (199,504) | 303,957 | 152.4% | 276,520 | (91,616) | 368,136 | 401.8% |
| Interest expense | 67,512 | 82,275 | (14,763) | (17.9)% | 195,233 | 259,290 | (64,057) | (24.7)% |
| Interest income | (8) | (81) | 73 | 90.1% | (19) | (229) | 210 | 91.7% |
| Loss on extinguishment of debt | 15,823 | — | 15,823 | 100.0% | 15,823 | — | 15,823 | 100.0% |
| Loss (gain) on investments | — | 7,784 | (7,784) | (100.0)% | (25) | 7,784 | (7,809) | (100.3)% |
| Change in fair value of Private Placement Warrants and unvested founder shares | (76,636) | — | (76,636) | (100.0)% | (35,451) | — | (35,451) | (100.0)% |
| **Net income (loss) before taxes** | 97,762 | (289,482) | 387,244 | 133.8% | 100,959 | (358,461) | 459,420 | 128.2% |
| Provision (benefit) for income taxes | 19,565 | (1,080) | 20,645 | NM | 23,817 | (11,219) | 35,036 | 312.3% |
| **Net income (loss)** | $78,197 | $(288,402) | $366,599 | 127.1% | $77,142 | $(347,242) | $424,384 | 122.2% |

NM = Not meaningful

#### Revenues

The increase in revenues for the three and nine months ended September 30, 2021 as compared to revenues for the three and nine months ended September 30, 2020 was primarily due to increases in claims volumes and changes in the mix of claims due to the reductions in COVID-19 restrictions on medical services that were in place in second and third quarter 2020, the acquisitions of DHP and HST and revenue growth from existing customers. Acquired revenues related to the acquisitions of DHP and HST were $12.4 million and $31.3 million for the three and nine months ended September 30, 2021, respectively.

Network-Based Services revenues increased in the three and nine months ended September 30, 2021 as compared to revenues for the three and nine months ended September 30, 2020 primarily due to increases in claims volumes and changes in the mix of claims due to the reduction in COVID-19 restrictions on medical services that were in place in second and third quarter 2020.

Analytics-Based Services revenues increased for the three and nine months ended September 30, 2021 as compared to revenues for the three and nine months ended September 30, 2020 primarily due to revenue growth through an increase in claims volume from existing customers, increases in claims volumes and changes in the mix of claims due to the reductions in COVID-19 restrictions on medical services that were in place in second and third quarter 2020, and the acquisition of HST.

Payment and Revenue Integrity Services revenues increased for the three and nine months ended September 30, 2021 as compared to revenues for the three and nine months ended September 30, 2020 primarily due to the acquisition of DHP and partially due to changes in the mix of claims due to the reductions in COVID-19 restrictions on medical services that were in place in second and third quarter 2020.

#### Costs of Services (exclusive of depreciation and amortization of intangible assets)

*($ in thousands)*

|  | Three Months Ended September 30, 2021 | 2020 | Change $% |  | Nine Months Ended September 30, 2021 | 2020 | Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cost of services (exclusive of depreciation and amortization of intangible assets) | $44,588 | $147,866 | $(103,278) | (69.8)% | $128,686 | $244,445 | $(115,759) | (47.4)% |
| Less: stock-based compensation | 1,719 | 108,777 | (107,058) | (98.4)% | 2,171 | 126,723 | (124,552) | (98.3)% |
| Costs of services excluding stock-based compensation | $42,869 | $39,089 | $3,780 | 9.7% | $126,515 | $117,722 | $8,793 | 7.5% |

The decrease in cost of services for the three and nine months ended September 30, 2021, as compared to the three and nine months ended September 30, 2020 was due to decreases in personnel expenses primarily related to stock-based compensation as explained below and decreases in access and bill review fees.

The decrease in personnel expenses, including contract labor, for the three and nine months ended September 30, 2021, as compared to the three and nine months ended September 30, 2020 was primarily due to decreases in stock-based compensation of $107.1 million and $124.6 million for the three and nine months ended September 30, 2021, as compared to the three and nine months ended September 30, 2020, respectively, partially offset by increases in other compensation related expenses, including salaries, bonus, commissions, fringe benefits and contract labor of $6.5 million and $12.9 million for the three and nine months ended September 30, 2021, respectively. The change in stock-based compensation expense over these time periods was primarily the result of changes in the stock-based compensation plans as described above in the Factors Affecting the Comparability of our Results of Operations.

The decrease in access and bill review fees was primarily due to reductions in network access fees for accessing non-owned third-party provider networks, primarily due to reduced volume and a renegotiated agreement with one of our large leased networks.

#### General and Administrative Expenses

*($ in thousands)*

|  | Three Months Ended September 30, 2021 | 2020 | Change $% |  | Nine Months Ended September 30, 2021 | 2020 | Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| General and administrative expenses | $38,221 | $176,380 | $(138,159) | (78.3)% | $110,144 | $234,147 | $(124,003) | (53.0)% |
| Less: stock-based compensation | 3,033 | 153,579 | (150,546) | (98.0)% | 11,023 | 172,905 | (161,882) | (93.6)% |
| Less: transaction-related expenses | 1,541 | 2,464 | (923) | (37.5)% | 7,972 | 5,162 | 2,810 | 54.4% |
| General and administrative expenses excluding stock-based compensation and transaction-related expenses | $33,647 | $20,337 | $13,310 | 65.4% | $91,149 | $56,080 | $35,069 | 62.5% |

The decrease in general and administrative expenses for the three months ended September 30, 2021, as compared to the three months ended September 30, 2020 was primarily due to a decrease in personnel expenses of $143.8 million, a decrease in transaction costs of $0.9 million, and an increase in the capitalized software development offset of $4.4 million, offset by an increase in insurance of $1.8 million primarily related to higher D&O insurance as a result of being a public company, an increase in professional fees of $2.9 million including higher legal, audit, and consulting fees, an increase in integration costs of $4.2 million primarily related to the acquisitions of HST and DHP, an increase in the loss on disposal of assets of $1.6 million as a result of a periodic review of capitalized computer hardware and software, and an increase in other general and administrative expenses of $0.4 million. The decrease in personnel expenses of $143.8 million was due to a decrease in stock-based compensation of $150.5 million, partially offset by an increase in other compensation related expenses, including salaries, bonus, fringe benefits, and contract labor of $6.7 million.

The decrease in general and administrative expenses for the nine months ended September 30, 2021, as compared to the nine months ended September 30, 2020 was primarily due to a decrease in personnel expenses of $148.0 million and an increase in the capital development offset of $4.7 million, offset by an increase in professional fees of $7.2 million including higher legal, audit, and consulting fees, an increase in insurance of $5.4 million primarily related to higher D&O insurance as a result of being a public company, an increase in transactions costs of $2.8 million, an increase in integration expenses of $8.8 million primarily related to the acquisitions of HST and DHP, an increase in equipment lease and maintenance expenses of $2.1 million, an increase in the loss on disposal of assets of $2.2 million based on a periodic review of capitalized computer hardware and software, and increase in other general and administrative expenses of $0.2 million. The decrease in personnel expenses of $148.0 million was due to a decrease in stock-based compensation of $161.9 million, partially offset by an increase in other compensation related expenses, including salaries, bonus, fringe benefits, and contract labor of $13.9 million. The increase in transactions costs of $2.8 million was primarily due to costs associated with the acquisition of DHP on February 26, 2021. See Note 2 Business Combinations of the notes to the unaudited condensed consolidated financial statements included in this Quarterly Report for additional information regarding the acquisition of DHP.

#### Depreciation Expense

The increase in depreciation expense for the three and nine months ended September 30, 2021 as compared to the three and nine months ended September 30, 2020 was due to purchases of property and equipment, including internally generated capitalized software in the nine months ended September 30, 2021 and year ended December 31, 2020, respectively, partially offset by assets that were written-off or became fully depreciated in the period.

#### Amortization of Intangible Assets

The increase in the amortization of intangible assets for the three and nine months ended September 30, 2021, as compared to the three and nine months ended September 30, 2020 was primarily due to the acquisitions of HST and DHP. This expense represents the amortization of intangible assets, as explained above and in the notes to the unaudited condensed consolidated financial statements.

#### Interest Expense

The decrease in interest expense for the three and nine months ended September 30, 2021, as compared to the three and nine months ended September 30, 2020 was due to the effect of (i) the Transactions on October 8, 2020 where we redeemed our

Senior PIK Notes (8.500% interest rate) and issued Convertible PIK Notes (6.000% interest rate), (ii) the Refinancing on October 29, 2020 where we prepaid $369.0 million of principal balance on Term Loan G and we redeemed the 7.125% Notes and issued 5.750% Notes, and (iii) the refinancing on August 24, 2021 where MPH issued new senior secured credit facilities comprised of Term Loan B and Revolver B, and issued the 5.50% Senior Secured Notes, using the net proceeds to repay all of the outstanding balance of Term Loan G.

In the years ended December 31, 2017, 2018 and 2019, we did not recognize expense for the portions of debt issuance costs related to the amounts of the principal loan prepayments made in each year, which resulted in an understatement of long-term debt of $2.3 million as of December 31, 2019. We corrected this error as an out-of-period adjustment resulting in an overstatement of interest expense of $2.3 million in the nine months ended September 30, 2020.

As of September 30, 2021, our long-term debt was $4,893.3 million and included (i) $1,325.0 million Term Loan B, discount on Term Loan B of $13.3 million, (ii) $1,050.0 million of 5.50% Senior Secured Notes, (iii) $1,300.0 million of 5.750% Senior Notes, (iv) $1,300.0 million of Senior Convertible PIK Notes, discount on Senior Convertible PIK Notes of $28.7 million (reduction in discount on Senior Convertible PIK Notes from December 30, 2020 relates to the adoption of ASU 2020-06 effective January 1, 2021), and (v) $0.1 million of long-term finance lease obligations, net of (vi) debt issue costs of $39.8 million. As of September 30, 2021, our total debt had an annualized weighted average cash interest rate of 4.85%.

As of December 31, 2020, our long-term debt was $4,578.5 million and included (i) $2,341.0 million Term Loan G, discount on Term Loan G of $3.8 million, (ii) $1,300.0 million of 5.750% Senior Notes, (iii) $1,300.0 million of Senior Convertible PIK Notes, discount on Senior Convertible PIK Notes of $329.5 million, and (iv) $0.1 million of long-term finance lease obligations, net of (v) debt issue costs of $29.3 million. As of December 31, 2020, our total debt had a weighted average interest rate of 4.91%

#### Loss on extinguishment of debt

As a result of the refinancing transactions of August 24, 2021, the Company recognized a loss on debt extinguishment of $15.8 million representing the difference between Term Loan G's net carrying amount immediately before the refinancing and the fair value of the new debt instruments, and fees associated with the issuance of the new debt under the refinancing.

#### Change in fair value of Private Placement Warrants and unvested founder shares

The Company remeasures the fair value of the Private Placement Warrants and unvested founder shares at each reporting period. From December 31, 2020 to September 30, 2021, the fair value of the Private Placement Warrants and the unvested founder shares decreased by $12.3 million and $23.2 million, respectively. The decrease was primarily due to the decrease in the stock price of the Company's Class A common stock over that period.

#### (Benefit) Provision for Income Taxes

Our effective tax rate for the nine months ended September 30, 2021 differed from the statutory rate primarily due to a non-deductible mark-to-market liability, impact of our acquisitions, changes in the Company's deferred state tax rate due to operations, and state tax expense. Our effective tax rate for nine months ended September 30, 2020 differed from the statutory rate primarily due to state taxes and stock-based compensation expense.

### Liquidity and Capital Resources

As of September 30, 2021, we had cash and cash equivalents of $225.1 million and $450.0 million of loan availability under the revolving credit facility. In connection with the Refinancing, the commitments under the revolving credit facility were increased from $100.0 million to $450.0 million and $369.0 million of indebtedness under the Term Loan G was repaid. On August 24, 2021, the maturity of the revolving credit facility was extended from June 7, 2023 to August 24, 2026. We have three letters of credit totaling $1.8 million as of September 30, 2021. The three letters of credit are used to satisfy real estate lease agreements for three of our offices in lieu of security deposits. Effective starting in fourth quarter 2020, these letters of credit are no longer utilized against the revolver. See Note 3 Long-Term Debt of the notes to the unaudited condensed consolidated financial statements included in this Quarterly Report for further information on the August 24, 2021 refinancing.

On August 27, 2021, the Company's Board of Directors approved a share repurchase program authorizing the Company to repurchase up to $250.0 million of its Class A common stock from time to time in open market transactions. The repurchase program was effective immediately and expires on December 31, 2022. As of September 30, 2021, the Company has repurchased $61.1 million of its Class A common stock as part of this program using cash on hand.

Our primary sources of liquidity are internally generated funds combined with our borrowing capacity under our revolving credit facility. We believe that these sources will provide sufficient liquidity for us to meet our working capital, capital expenditure and other cash requirements for at least the next twelve months. We may from time to time at our sole discretion, purchase, redeem or retire our long-term debt, through tender offers, in privately negotiated or open market transactions or otherwise. We plan to finance our capital expenditures with cash from operations. Furthermore, our future liquidity and future ability to fund capital expenditures, working capital and debt requirements are also dependent upon our future financial performance, which is subject to many economic, commercial, financial and other factors that are beyond our control, including the ability of financial institutions to meet their lending obligations to us. If those factors significantly change, our business may not be able to generate sufficient cash flow from operations or future borrowings may not be available to meet our liquidity needs. We anticipate that to the extent we require additional liquidity as a result of these factors or in order to execute our strategy, it would be financed either by borrowings under our senior secured credit facilities, by other indebtedness, additional equity financings or a combination of the foregoing. We may be unable to obtain any such additional financing on reasonable terms or at all.

### Cash Flow Summary

The following table is derived from our unaudited condensed consolidated statements of cash flows:

*(in thousands)*

| Net cash flows provided by (used in): | Nine Months Ended September 30, 2021 | 2020 |
| --- | ---: | ---: |
| Operating activities | $371,426 | $332,301 |
| Investing activities | $(201,197) | $(150,328) |
| Financing activities | $(71,844) | $9 |

### Cash Flows from Operating Activities

Cash flows from operating activities provided $371.4 million for the nine months ended September 30, 2021 and $332.3 million for the nine months ended September 30, 2020. This $39.1 million increase in cash flows from operating activities was primarily the result of an increase in net income of $424.4 million, offset by a decrease in adjustments for non-cash items of $339.8 million and an increase in net working capital of $45.5 million.

The $339.8 million decrease in non-cash items was primarily due to a decrease in deferred income taxes of $32.6 million, a decrease in the change in fair value of Private Placement Warrants and unvested founder shares of $35.5 million, a decrease in stock-based compensation of $286.4 million, a decrease in loss on equity investments of $7.8 million, a decrease in non-cash interest costs of $3.0 million including decreases in debt issue costs, and a decrease in amortization of right of use asset of $1.2 million, offset by an increase in loss on extinguishment of debt of $15.8 million, an increase in depreciation of $4.1 million, an increase in amortization of intangible assets of $4.5 million, and an increase in loss on disposal of property and equipment of $2.3 million.

During the nine months ended September 30, 2021, $46.5 million was provided by changes in net working capital including an increase in accounts payable and accrued expenses and other expenses of $47.3 million and a decrease in prepaid expenses and other assets of $4.7 million, offset by an increase in prepaid taxes of $— million, an increase in net accounts receivable of $0.5 million primarily due to timing of collections, and a decrease in operating lease obligations of $5.0 million. The increase in accounts payable and accrued expenses and other expenses of $47.3 million was primarily due to an increase in accrued interest of $48.8 million and accrued compensation of $17.8 million, offset by $10.2 million in accrued taxes, and $9.1 million of other accounts payable and accrued expenses.

During the nine months ended September 30, 2020, $92.0 million was provided by changes in net working capital including a decrease in net accounts receivable of $23.2 million primarily due to declines in year-over-year revenues and timing of collections, a decrease in prepaid taxes of $2.1 million primarily due to a retrospective change in the tax law, an increase in accounts payable and accrued expenses and other expenses of $107.0 million primarily due to accrued transactions costs and accrued interest, offset by an increase in prepaid expenses and other assets of $34.3 million due to prepayment of deferred transaction costs, and a decrease in operating lease obligations of $6.1 million.

### Cash Flows from Investing Activities

For the nine months ended September 30, 2021, net cash of $201.2 million was used in investing activities including $149.7 million for the acquisition of DHP and $57.2 million for purchases of property and equipment and capitalization of software development, offset by proceeds from the sale of an investment of $5.6 million. For the nine months ended September 30, 2020, net cash of $150.3 million was used in investing activities including $49.3 million for purchases of property and equipment and capitalization of software development and $101.0 million of purchases of equity investments.

### Cash Flows from Financing Activities

Cash flows used in financing activities for the nine months ended September 30, 2021 were $71.8 million consisting primarily of repayments of Term Loan G of $2,341.0 million, $61.1 million of purchases of treasury stock, and $3.3 million of taxes paid on net settlement of vested share awards, offset by the issuance of Term Loan B of $1,299.0 million and the issuance of $1,034.6 million of the 5.50% Senior Secured Notes.

Cash flows provided in financing activities for the nine months ended September 30, 2020 consisted of $98.0 million of borrowings and $98.0 million of repayments on Revolver G.

### Term Loans and Revolvers

On August 24, 2021, MPH issued new senior secured credit facilities comprised of $1,325.0 million of Term Loan B and $450.0 million of Revolver B, and $1,050.0 million in aggregate principal amount of 5.50% Senior Secured Notes. MPH used the net proceeds from Term Loan B, issued with a discount of 1.00%, and the 5.50% Senior Secured Notes to repay all of the outstanding balance of its Term Loan G of $2,341.0 million, and pay fees and expenses in connection therewith.

Interest on Term Loan B and Revolver B is calculated, at MPH's option, as (a) LIBOR (or, with respect to Term Loan B only, 0.50%, if higher), plus the applicable margin, or (b) the highest rate of (1) the prime rate, (2) the federal funds effective rate, plus 0.50%, (3) the LIBOR for an interest period of one month plus 1.00% and (4) 0.50% for Term Loan B and 1.00% for Revolver B, in each case, plus an applicable margin of 4.25% for Term Loan B and between 3.50% and 4.00% for Revolver B, depending on MPH's first lien debt to consolidated EBITDA ratio. The interest rate in effect for Term Loan B was 4.75% as of September 30, 2021 and the interest rate in effect for Term Loan G was 3.75% as of September 30, 2020.

Term Loan B matures on September 1, 2028 and Revolver B matures on August 24, 2026.

For all our debt agreements with an interest rate dependent on LIBOR, we are currently assessing and monitoring how transitioning from LIBOR to an alternative reference rate may affect us past 2023.

We are obligated to pay a commitment fee on the average daily unused amount of our revolving credit facility. The annual commitment fee rate was 0.50% at September 30, 2021 and 0.25% at September 30, 2020. The fee can range from an annual rate of 0.25% to 0.50% based on our leverage ratio, as defined in the agreement.

### Senior Notes

On October 8, 2020, the Senior PIK notes were redeemed in full for a total redemption price of $1,237.6 million, which included a redemption premium and accrued interest. The interest rate on the Senior PIK Notes was fixed at 8.5% and was payable semi-annually on June 1 and December 1 of each year.

On October 8, 2020, the Company issued $1,300.0 million in aggregate principal amount of Senior Convertible PIK Notes. The Senior Convertible PIK Notes were issued with a 2.5% discount with a maturity date of October 15, 2027. Prior to the adoption of ASU 2020-06 on January 1, 2021, the nature of the notes required management to separate the Senior Convertible PIK Notes into liability and equity components. ASU 2020-06’s elimination of the beneficial conversion guidance resulted in "recombining" the equity and debt components of the Senior Convertible PIK Notes into a single liability. As a result, $297.9 million of the discount on the liability created by recognition of a component of the convertible debt in equity was eliminated. See Note 1 General Information and Basis of Accounting and Note 3 Long-Term Debt of the notes to the unaudited condensed consolidated financial statements included in this Quarterly Report for further detail.

The Senior Convertible PIK Notes are convertible into shares of Class A common stock based on a $13.00 conversion price, subject to customary anti-dilution adjustments. The interest rate on the Senior Convertible PIK Notes is fixed at 6% in cash and 7% in kind, and is payable semi-annually on April 15 and October 15 of each year.

On October 29, 2020, the 7.125% Notes were redeemed in full for a total redemption price of $1,661.3 million, which included a redemption premium and accrued interest. The interest rate on the 7.125% Notes was fixed at 7.125% and was payable semi-annually on June 1 and December 1 of each year.

On October 29, 2020, the Company issued $1,300.0 million in aggregate principal amount of the 5.750% Notes. The 5.750% Notes are guaranteed on a senior unsecured basis jointly and severally by the Company and its subsidiaries and have a maturation date of November 1, 2028. The 5.750% Notes were issued at par. The interest rate on the 5.750% Notes is fixed at 5.750%, and is payable semi-annually on May 1 and November 1 of each year.

On August 24, 2021 MPH issued $1,050.0 million in aggregate principal amount of 5.50% Senior Secured Notes with a maturation date of September 1, 2028. The interest rate on the 5.50% Senior Secured Notes is fixed at 5.50%, and is payable semi-annually on March 1 and September 1 of each year. The 5.50% Senior Secured Notes are guaranteed and secured as described below under “—Guarantees and Security.”

### Debt Covenants and Events of Default

We are subject to certain affirmative and negative debt covenants under the debt agreements governing our indebtedness that limit our and/or certain of our subsidiaries' ability to engage in specific types of transactions. These covenants limit our and/or certain of our subsidiaries' ability to, among other things:

- incur additional indebtedness or issue disqualified or preferred stock;
- pay certain dividends or make certain distributions on capital stock or repurchase or redeem capital stock;
- make certain loans, investments or other restricted payments;
- transfer or sell certain assets;
- incur certain liens;
- place restrictions on the ability of its subsidiaries to pay dividends or make other payments to us;
- guarantee indebtedness or incur other contingent obligations;
- prepay junior debt and make certain investments;
- consummate any merger, consolidation or amalgamation, or liquidate, wind up or dissolve itself (or suffer any liquidation or dissolution), or dispose of all or substantially all of its business units, assets or other properties; and
- engage in transactions with our affiliates.

Certain covenants related to the 5.50% Senior Secured Notes will cease to apply to the 5.50% Senior Secured Notes for so long as such notes have investment grade ratings from both Moody’s Investors Service, Inc. and S&P Global Ratings.

In connection with the Refinancing, the Revolver Ratio was amended such that, if, as of the last day of any fiscal quarter of MPH, the aggregate amount of loans under the revolving credit facility, letters of credit issued under the revolving credit facility (to the extent not cash collateralized or backstopped or, in the aggregate, in excess of $10.0 million) and swingline loans are outstanding and/or issued in an aggregate amount greater than 35% of the total commitments in respect of the revolving credit facility at such time, the revolving credit facility will require MPH to maintain a maximum first lien secured leverage ratio of 6.75 to 1.00. Our consolidated first lien debt to consolidated EBITDA ratio is 2.68 times and 3.14 times as of September 30, 2021 and December 31, 2020, respectively.

As of September 30, 2021 and December 31, 2020 we were in compliance with all of the debt covenants.

The debt agreements governing the new senior secured credit facilities, Term Loan G, the Revolver G, the 5.750% Notes and the 5.50% Senior Secured Notes contain customary events of default, subject to grace periods and exceptions, which include, among others, payment defaults, cross-defaults to certain material indebtedness, certain events of bankruptcy, material judgments, in the case of the debt agreements governing the new senior secured credit facilities and the 5.50% Senior Secured Notes, failure of a guarantee on the liens on material collateral to remain in effect, in the case of the debt agreements governing the new senior secured credit facilities, Term Loan G and the Revolver G, any change of control. Upon the occurrence of an event of default under such debt agreements, the lenders and holders of such debt will be permitted to accelerate the loans and terminate the commitments, as applicable, thereunder and exercise other specified remedies available to the lenders and holders thereunder.

See the footnotes to the EBITDA and Adjusted EBITDA reconciliation table provided above under "*Non-GAAP Financial Measures*" for material differences between the financial information of MultiPlan and MPH.

### Guarantees and Security

All obligations under the debt agreements governing Term Loan B, Revolver B and the 5.50% Senior Secured Notes are unconditionally guaranteed by MPH Acquisition Corp. 1, the direct holding company parent of MPH, and each existing and subsequently acquired or organized direct or indirect wholly owned U.S. organized restricted subsidiary of MPH (subject to certain exceptions). All such obligations, and the guarantees of such obligations, are secured, subject to permitted liens and other exceptions, by a first priority lien shared between the senior secured credit facilities and the 5.50% Senior Secured Notes on substantially all of MPH’s and the subsidiary guarantors’ tangible and intangible property, and a pledge of all of the capital stock of each of their respective subsidiaries.

### Critical Accounting Policies

In preparing our Unaudited Condensed Consolidated Financial Statements, we are required to make judgments, assumptions and estimates, which we believe are reasonable and prudent based on the available facts and circumstances. These judgments, assumptions and estimates affect certain of our revenues and expenses and their related balance sheet accounts and disclosure of our contingent liabilities. We base our assumptions and estimates primarily on historical experience and consider known and projected trends. On an ongoing basis, we re-evaluate our selection of assumptions and the method of calculating our estimates. Actual results, however, may materially differ from our calculated estimates, and this difference would be reported in our current operations.

For a detailed description of our critical accounting estimates, see “*Management’s Discussion and Analysis of Financial Condition and Results of Operations”* in Part II, Item 7 in our 2020 Annual Report. For a detailed discussion of our significant accounting policies, see Note 2 of Notes to the Consolidated Financial Statements in Part II, Item 8, “*Financial Statements and Supplementary Data”* in our 2020 Annual Report. As of September 30, 2021, our critical accounting policies and estimates have not changed from those described in our 2020 Annual Report, except for the policies related to convertible notes, which changed as a result of the adoption of a new accounting pronouncement, and stock-based compensation, which changed as a result of the grant of stock options and Fixed Value RSUs.

### Customer Concentration

Two customers individually accounted for 35% and 20% of revenues for the year ended December 31, 2020. The loss of the business of one or more of our larger customers could have a material adverse effect on our results of operations.

### Recent Accounting Pronouncements

See Note 1 General Information and Basis of Accounting of the Notes to the unaudited condensed consolidated financial statements included in this Quarterly Report for additional information.

### Quantitative and Qualitative Disclosure About Market Risk

See Item 3. Quantitative and Qualitative Disclosure about Market Risk below.

### Internal Controls Over Financial Reporting

For further information on the Company’s internal controls over financial reporting see Item 4. Controls and Procedures.

## Market risk

As filed, 254 characters.

Reference is made to our 2020 Annual Report and in particular Item 7A.“*Quantitative and Qualitative Disclosure about Market Risk”* therein. As of September 30, 2021, there were no material changes in the market risks described in our 2020 Annual Report.

## Controls and procedures

As filed, 6,813 characters.

### Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including the Company’s principal executive officer and principal financial and accounting officer, the Company conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officers have concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of September 30, 2021, solely as a result of the following material weaknesses in internal control over financial reporting.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. As described in our annual report on Form 10-K for the year ended December 31, 2020, management determined that the following control deficiencies that constituted material weaknesses in our internal control over financial reporting existed as of December 31, 2020 and continue to exist as of September 30, 2021:

- We did not maintain a sufficient complement of resources with an appropriate level of accounting knowledge and experience commensurate with the financial reporting requirements for a public company, including condensed timelines to close and sufficient oversight of internal controls over financial reporting.
- We did not maintain sufficient formal accounting policies, procedures, and controls for accounting and financial reporting with respect to the requirements and application of public company financial reporting requirements, including accounting for debt and equity arrangements.

These material weaknesses did not result in any material misstatements to our unaudited condensed consolidated financial statements for the three months ended September 30, 2021.

### Remediation of Material Weaknesses

In 2020, the Company took the following actions to remediate the material weaknesses:

- The Company hired a Senior Vice President and Chief Accounting Officer, a Vice President of Internal Audit, and an Assistant Vice President and Assistant General Counsel, Securities in September 2020, October 2020, and December 2020, respectively.
- The Company engaged a professional services firm to assist in the design and documentation of formal policies, procedures and internal controls.

Building on our efforts during 2020, during the first three quarters of 2021, the Company took the following additional actions:

- The Company hired a Senior Vice President of Finance and Investor Relations and strengthened the financial reporting and technical accounting team with individuals who have significant experience in technical accounting matters and internal controls.
- The Company prepared a risk assessment of key controls. Through this analysis, the Company is identifying areas where new controls are needed as well as areas where control enhancements to existing controls are necessary. The Company will further develop and implement these controls as part of the close process and will continue to enhance or modify these controls in future periods if needed.
- The Company started the evaluation of its key internal controls over financial reporting covering entity-level controls, and business process controls. Upon completion of the interim testing of key controls, Management will continue to

assess its internal controls, remediate any identified deficiencies and continue to enhance its key financial reporting controls.

- The Company worked to strengthen the internal control environment by conducting training on policies and procedures, standardizing business practices, improving communication, leadership, and process improvement within various financial functional areas.
- The Company established a repeatable formal process and timeline for periodic financial close and reporting which supports public company reporting requirements. An SEC Reporting solution was implemented to complement the public company reporting process.
- The Company continues to evaluate the need for additional resources with the requisite knowledge of accounting and financial reporting while supplementing existing resources with temporary resources to assist with performing technical accounting activities.

We believe the measures described above will facilitate the remediation of the control deficiencies we have identified and strengthen our internal control over financial reporting. We are committed to continuing to improve our internal control processes and will continue to review, optimize and enhance our financial reporting controls and procedures. As we continue to evaluate and work to improve our internal control over financial reporting, we may take additional measures to address control deficiencies, or we may modify certain of the remediation measures described above. These material weaknesses will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. Accordingly, the material weaknesses are not remediated as of September 30, 2021.

### Changes in Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting during the three months ended September 30, 2021 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

### Inherent Limitations on Effectiveness of Controls

Management recognizes that a control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, have been detected.

## Risk factors

As filed, 2,666 characters.

There have been no material changes, except for the following, during the nine months ended September 30, 2021 to the risk factors previously disclosed in Item 1A. “*Risk Factors”* in the Company's 2020 Annual Report.

***Our Private Placement Warrants and unvested founder shares are accounted for as derivative liabilities and changes in fair value for each period are reported in earnings, which may have an adverse effect on the market price of our Class A common stock.***

As of September 30, 2021, we had Private Placement Warrants exercisable for an aggregate of 24,500,000 shares of our Class A common stock and unvested founder shares contingently issuable for an aggregate of 12,404,080 shares of our Class A common stock outstanding. We account for the Private Placement Warrants and unvested founder shares as liabilities. At each reporting period (i) the accounting treatment of the Private Placement Warrants and unvested founder shares will be re-evaluated for proper accounting treatment as a liability or equity and (ii) the fair value of the liability of the Private Placement Warrants and unvested founder shares will be remeasured and the change in the fair value of the liability will be recorded as Change in fair value of Private Placement Warrants and unvested founder shares in our Statements of Loss and Comprehensive Loss. Changes in the inputs and assumptions for the valuation model we use to determine the fair value of such liability may have a material impact on the estimated fair value of the embedded derivative liability. The share price of our Class A common stock represents the primary underlying variable that impacts the value of the derivative instruments. Additional factors that impact the value of the derivative instruments include the volatility of our stock price, risk-free rate and discount for lack of marketability. As a result, our consolidated financial statements and results of operations will fluctuate quarterly, based on various factors, such as the share price of our Class A common stock, many of which are outside of our control. In addition, we may change the underlying assumptions used in our valuation model, which could result in significant fluctuations in our results of operations. If our stock price is volatile, we expect that we will recognize non-cash gains or losses on the outstanding Private Placement Warrants, unvested founder shares or any other similar derivative instruments each reporting period and that the amount of such gains or losses could be material. The impact of changes in fair value on earnings may have an adverse effect on the market price of our Class A common stock.

Filed Nov 4, 2021.
Source: SEC EDGAR, the filing index for accession 0001793229-21-000106. Last ingested by Listed: Nov 15, 2026, 00:46 ET. No prices; not investment advice.
